Prof. BÜLENT ELİBOL

Publication Network

Articles 22

1. Effect of freezing phenomenon on gait parameters and pedobarographic pressure distribution in patients with Parkinson’s disease

Korkusuz S., SEÇKİNOĞULLARI KORKUSUZ B., Demircan E. N., Özcan A., Çakmaklı G. Y., FİL BALKAN A., et al.

Neurological Sciences , vol.47, no.1, 2026 (SCI-Expanded, Scopus)

2. Novel prostaglandin and isoprostane panel for evaluating Wilson's Disease

Polat M. B., Durukan B. M., Israfilov S., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., DAĞ O., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.50, no.6, pp.870-877, 2025 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

3. Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders

Cinar E., Yalcin-Cakmakli G., Akyel H., Ulusoy A., TEL B. C., Elibol B.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.257, 2025 (SCI-Expanded, Scopus) Sustainable Development

4. Remodeling of Perineuronal Nets in the Striato-Cortical Axis in L-DOPA-Induced Dyskinesia Rat Model

Bilbay N. T., TEL B. C., Akkus G., ÇAKIR AKTAŞ C., Solakoglu T., YALÇIN ÇAKMAKLI G., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.26, no.23, 2025 (SCI-Expanded, Scopus)

5. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ TURAN B., Yalcin-cakmakli G., ERGÜN E., Dasgin H., Karli Oguz K., ELİBOL B., et al.

ANNALS OF NUCLEAR MEDICINE , 2025 (SCI-Expanded, Scopus)

6. The impact of perioperative aspirin utilization on postoperative hemorrhagic complications in idiopathic normal pressure hydrocephalus: a single-center retrospective analysis

IŞIKAY A. İ., ÇEKİÇ E., Charehsaz A., Uyaniker Z. A., YALÇIN ÇAKMAKLI G., GÖÇMEN R., et al.

NEUROSURGICAL REVIEW , no.1, 2025 (SCI-Expanded, Scopus)

7. Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia?

Ismayilov R., ÖZÜM T., ERSAL DEREGÖZÜ E., Israfilov S., Abdurrahimli N., YALÇIN ÇAKMAKLI G., et al.

HEPATOLOGY FORUM , vol.6, no.1, pp.11-15, 2025 (ESCI, TRDizin)

8. Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration

Susgun S., DEMİREL M., YALÇIN ÇAKMAKLI G., Salman B., Oguz K. K., ELİBOL B., et al.

International Journal of Neuroscience , no.10, pp.1040-1045, 2024 (SCI-Expanded, Scopus)

9. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

Westenberger A., Skrahina V., Usnich T., Beetz C., Vollstedt E., Laabs B., et al.

BRAIN , vol.147, no.8, pp.2652-2667, 2024 (SCI-Expanded, Scopus)

10. Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis

Onal G., YALÇIN ÇAKMAKLI G., Özçelik C., Boussaad I., Şeker U., Fernandes H. J. R., et al.

Journal of Neurochemistry , 2024 (SCI-Expanded, Scopus)

11. Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?

ERDOĞAN S., YALÇIN ÇAKMAKLI G., ELİBOL B., CEYLANER S., AKBOSTANCI M. C.

Acta Neurologica Belgica , vol.123, no.6, pp.2441-2444, 2023 (SCI-Expanded, Scopus)

12. Disclosing the news of future risk of Parkinson's disease: What do patients think?

YILMAZ R., Dilek G. R., Kayis G., Abali T., YALÇIN ÇAKMAKLI G., ARDA B., et al.

Parkinsonism and Related Disorders , vol.116, 2023 (SCI-Expanded, Scopus)

13. Cockayne syndrome type 3 with dystonia-ataxia and clicking blinks

GÜLTEKİN ZAİM Ö. B., YALÇIN ÇAKMAKLI G., Çolpak A. İ., ŞİMŞEK KİPER P. Ö., ÜTİNE G. E., ELİBOL B.

Movement Disorders Clinical Practice , vol.10, no.S3, 2023 (SCI-Expanded, Scopus)

14. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis

Erkent I., ELİBOL B., Saka E., SAYGI S., Tezer I.

Neurological Sciences , vol.44, no.4, pp.1351-1360, 2023 (SCI-Expanded, Scopus)

15. Do cervical stabilization exercises change the effects of conventional exercises in patients with Parkinson’s disease?

Demircan E. N., KÖSE N., Çakmaklı G. Y., AKSOY S., GÖÇMEN R., ZENGİN H. Y., et al.

Neurological Research , vol.45, no.10, pp.936-946, 2023 (SCI-Expanded, Scopus)

16. Comparative analysis of freezing of gait in distinct Parkinsonism types by diffusion tensor imaging method and cognitive profiles

Onder H., Oguz K. K., Has A. C., ELİBOL B.

Journal of Neural Transmission , vol.130, 2023 (SCI-Expanded, Scopus)

17. Acute effects of lumbosacral mobilization on balance and functional activities in idiopathic Parkinson’s disease:A randomised controlled trial

Seçkinoğulları B., Balkan A. F., Çakmaklı G. Y., AKSOY S., ELİBOL B.

Neurological Research , vol.45, no.8, pp.745-752, 2023 (SCI-Expanded, Scopus)

18. Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE-PD observational study

Fasano A., Fung V. S. C., Seppi K., Pirtosek Z., Takats A., Alobaidi A., et al.

ACTA NEUROLOGICA SCANDINAVICA , vol.146, no.2, pp.167-176, 2022 (SCI-Expanded, Scopus)

19. Novel WDR45 frameshift variant detected by whole exome sequencing in beta-propeller protein-associated neurodegeneration disease

Susgun S., DEMİREL M., YALÇIN ÇAKMAKLI G., ELİBOL B., Iseri S. U., Yapici Z.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.304-305, 2022 (SCI-Expanded, Scopus)

20. Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment

Saka E., ELİBOL B., ERDEM ÖZDAMAR S., Dalkara T.

Brain Research , vol.825, no.1-2, pp.104-114, 1999 (SCI-Expanded, Scopus)

21. Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients

Anlar B., Söylemezoǧlu F., ELİBOL B., DALKARA T., AYSÜN S., Kose G., et al.

Neuropediatrics , vol.30, no.5, pp.239-242, 1999 (SCI-Expanded, Scopus)

22. Effects of freezing of gait on balance in patients with Parkinson’s disease

Korkusuz S., Seçkinoğulları B., Özcan A., Demircan E. N., Çakmaklı G. Y., ARMUTLU K., et al.

Neurological Research , vol.45, no.5, pp.407-414, 1 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 9

1. Wilson Hastalığı Tedavisinde Serum Değişken ve Göreceli Değişken Bakır Testleri 24 Saatlik İdrar Bakır Atılımına Alternatif Olabilir mi?

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., ŞAHİN T., ELİBOL B., DAĞ O.

39. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 22 November 2022, (Summary Text)

2. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER CORRELATE WITH MULTIPARAMETRIC LIVER MRI PARAMETERS IN PATIENTS WITH WILSON DISEASE

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., ŞAHİN T., PINAR A., et al.

AASLD, Washington, Kiribati, 10 November 2022, vol.76, pp.1119-1120, (Summary Text)

3. CAN SERUM EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER BE ALTERNATIVE TESTS TO 24-HOUR URINARY COPPER EXCREATION IN PATIENTS ON TREATMENT FOR WILSON DISEASE?

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PINAR A., ELİBOL B.

AASLD 2022, United States Of America, 10 November 2022, vol.76, pp.1117, (Summary Text)

4. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER LEVELS WERE SIMILAR IN WILSON DISEASE PATIENTS WITH AND WITHOUT OF CRANIAL MRI INVOLMENT

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PARLAK Ş., ŞAHİN T., PINAR A., et al.

AASLD, Washington, Kiribati, 10 November 2022, vol.76, pp.1120-1121, (Summary Text)

5. Kronik stresin bellek üzerine etkileri dişi ile erkek farelerde farklı mı?

ESEN E. C., YALÇIN ÇAKMAKLI G., KARATAŞ KURŞUN H., YEMİŞCİ ÖZKAN M., DALKARA T., ELİBOL B., et al.

Ulusal Sinirbilim Kongresi, Turkey, 07 November 2020, (Summary Text)

6. 2000-2017 yılları arası izlenen Anti-GAD pozitif nörolojik sendrom olgularının klinik, laboratuvar ve görüntüleme özellikleri ve immün tedavi yanıtları

ERKENT İ., GÖÇMEN R., TUNCER M. A., TAN M. E., ELİBOL B., SAYGI S., et al.

54. Ulusal nöroloji kongresi, Turkey, 30 November - 06 December 2018, pp.53, (Summary Text)

7. 30 yıl sonra gelişen relaps ile tanınan nmda ensefaliti olgusu

MUTLU D., TUNCER M. A., SAYGI S., ELİBOL B., SAKA TOPÇUOĞLU E.

54. ulusal nöroloji kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

8. Does higher alpha-synuclein aggregate density lead to more severe dopaminergic cell loss in the AAV-mediated over-expression model of PD?

ÇINAR E., YALÇIN ÇAKMAKLI G., Mutluay S. U., TELLİ G., KAZKAYASI İ., ULUSOY A., et al.

19th International of Parkinson’s Disease and Movement Disorders, United States Of America, 14 June 2015, (Summary Text)

9. Adeno İlişkili Viral Vektör Aracılı Parkinson Hastalığı Modeli Alfa Sinüklein Aşırı İfadesinin Neden Olduğu Motor Değişiklikler ve Histopatolojik Karşılıkları

ÇINAR E., KAZKAYASI İ., TELLİ G., Sevgi Uğur M., YALÇIN ÇAKMAKLI G., SAKA TOPÇUOĞLU E., et al.

22. Ulusal Farmakoloji Kongresi, Antalya, Antalya, Turkey, 4 - 07 November 2013, (Summary Text)

Metrics

Publication

122

Publication (WoS)

Publication (Scopus)

Citation (WoS)

699

H-Index (WoS)

Citation (Scopus)

816

H-Index (Scopus)

Project

Open Access

UN Sustainable Development Goals

Publications & Works